MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

por Ali, S, Saleh, H, Sethi, S, Sarkar, F H, Philip, P A
Publicado 2012

The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

por Philip, P. A., Kaklamanis, L., Carmichael, J., Tonkin, K., Morrison, H., Gatter, K., Harris, A. L.
Publicado 1993

Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.

por Philip, P. A., Carmichael, J., Tonkin, K., Buamah, P. K., Britton, J., Dowsett, M., Harris, A. L.
Publicado 1993

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.

por Philip, P. A., Joel, S., Monkman, S. C., Dolega-Ossowski, E., Tonkin, K., Carmichael, J., Idle, J. R., Harris, A. L.
Publicado 1992

Bone disease in testicular and extragonadal germ cell tumours.

por Hitchins, R. N., Philip, P. A., Wignall, B., Newlands, E. S., Begent, R. H., Rustin, G. J., Bagshawe, K. D.
Publicado 1988

In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.

por Philip, P. A., Bagshawe, K. D., Searle, F., Green, A. J., Begent, R. H., Newlands, E. S., Rustin, G. J., Adam, T.
Publicado 1991

Phase I study of the mitomycin C analogue BMS-181174.

por Macaulay, V. M., O'Byrne, K. J., Green, J. A., Philip, P. A., McKinley, L., LaCreta, F. P., Winograd, B., Ganesan, T. S., Harris, A. L., Talbot, D. C.
Publicado 1998